4d Molecular Therapeutics In shares owned by BlackRock
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $137M | 4.3M | 31.86 |
| 2023-09-30 | $40M | 3.1M | 12.73 |
| 2023-06-30 | $53M | 2.9M | 18.07 |
| 2023-03-31 | $44M | 2.6M | 17.19 |
| 2022-12-31 | $56M | 2.5M | 22.21 |
| 2022-06-30 | $15M | 2.2M | 6.97 |
| 2021-06-30 | $18M | 731k | 24.08 |
| 2021-03-31 | $24M | 547k | 43.46 |
| 2020-12-31 | $246k | 5.9k | 41.50 |